H. Arias

发表

Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.

J. Trudell, M. P. Blanton, H. Arias, 2003, Biochemistry.

Angiogenesis modulation by nicotine and nicotinic ligands

S. Mousa, H. Arias, 2016 .

Role of Non-neuronal Nicotinic Acetylcholine Receptors in Angiogenesis Modulation

S. Mousa, H. Arias, P. Davis, 2013 .

Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis.

S. Mousa, H. Arias, Victoria E. Richards, 2009, The international journal of biochemistry & cell biology.

Jans H. Alzate-Morales, H. Arias, Gabriel Núñez-Vivanco, 2015, PloS one.

Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives.

Kuo-Chen Chou, Dong-Qing Wei, Qi-Shi Du, 2005, Biochemical and biophysical research communications.

Marine Toxins Targeting Ion Channels

H. Arias, Hugo R. Arias, 2006, Marine Drugs.

Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules

H. Arias, 1998, Journal of neuroscience research.

Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors

H. Arias, Hugo Rubén Arias, 2000, Neurochemistry International.

Topology of ligand binding sites on the nicotinic acetylcholine receptor

H. Arias, Hugo R Arias, 1997, Brain Research Reviews.

Composition of Lipids in Elasmobranch Electric Organ and Acetylcholine Receptor Membranes

H. Arias, F. Barrantes, N. Rotstein, 1987, Journal of neurochemistry.

The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice

H. Arias, B. Budzyńska, Katarzyna M Targowska-Duda, 2016, Behavioural Brain Research.

Neuronal networks of nicotine addiction.

H. Arias, M. Ortells, 2010, The international journal of biochemistry & cell biology.

Association of spin-labeled local anesthetics at the hydrophobic surface of acetylcholine receptor in native membranes from Torpedo marmorata.

K. Hideg, H. Arias, F. Barrantes, 1990, Biochemistry.

Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria.

U. Maskos, H. Arias, S. Pons, 2018, The international journal of biochemistry & cell biology.

Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with alpha7 nicotinic acetylcholine receptor.

K. Chou, Dongqing Wei, H. Arias, 2009, Medicinal chemistry (Shariqah (United Arab Emirates)).

Coronaridine congeners modulate mitochondrial α3β4* nicotinic acetylcholine receptors with different potency and through distinct intra-mitochondrial pathways

H. Arias, M. Skok, O. Lykhmus, 2018, Neurochemistry International.

Review a-Conotoxins

M. P. Blanton, H. Arias, 2000 .

3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of α7 nicotinic receptors, produces anxiolytic-like activity in mice

H. Arias, A. Michalak, B. Budzyńska, 2019, Journal of psychopharmacology.

Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms.

H. Arias, A. Elgoyhen, D. Feuerbach, 2018, The international journal of biochemistry & cell biology.

Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.

H. Arias, Xiao-tao Jin, R. Drenan, 2017, The international journal of biochemistry & cell biology.

Functional and Structural Interaction of ( 2 )-Reboxetine with the Human a 4 b 2 Nicotinic Acetylcholine Receptor

H. Arias, G. Gatto, P. Lippiello, 2012 .

Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors.

H. Arias, D. Feuerbach, M. Ortells, 2010, The international journal of biochemistry & cell biology.

The β4 nicotinic receptor subunit modulates the chronic antidepressant effect mediated by bupropion

H. Arias, A. Santamaría, R. Radhakrishnan, 2013, Neuroscience Letters.

Phosphoinositides and inositol phosphates in Discopyge tschudii electrocyte membranes

H. Arias, F. Barrantes, 1990 .

Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.

J. Trudell, H. Arias, C. Bouzat, 2006, Biochemistry.

Anesthetics as chemical tools to study the structure and function of nicotinic acetylcholine receptors.

H. Arias, Pankaj Bhumireddy, 2005, Current protein & peptide science.

Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?

H. Arias, Katarzyna M Targowska-Duda, J. García-Colunga, 2021, Molecules.

Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.

Dongqing Wei, H. Arias, R. Gu, 2011, Biochemistry.

Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective

H. Arias, C. Bouzat, D. Feuerbach, 2016, Neuropharmacology.

In vitro turnover of oleate and arachidonate in lipids of Discopyge tschudii electrocyte membranes

H. Arias, F. Barrantes, 1987 .

The role of inflammation in Alzheimer's disease.

H. Arias, Ehab E Tuppo, Hugo R Arias, 2005, The international journal of biochemistry & cell biology.

(E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor Potentiation.

H. Arias, David John Adams, C. Ghelardini, 2020, ACS chemical neuroscience.

Nicotine smoking concentrations modulate GABAergic synaptic transmission in murine medial prefrontal cortex by activation of α7* and β2* nicotinic receptors

M. Atzori, H. Arias, N. Saderi, 2020, The European journal of neuroscience.

Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors.

H. Arias, C. Bouzat, Pankaj Bhumireddy, 2006, The international journal of biochemistry & cell biology.

Unique general anesthetic binding sites within distinct conformational states of the nicotinic acetylcholine receptor.

J. Trudell, M. P. Blanton, H. Arias, 2003, International review of neurobiology.

Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor.

H. Arias, E. McCardy, M. Blanton, 2001, Molecular pharmacology.

Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors

H. Arias, 1999, Neuroscience & Biobehavioral Reviews.

Modulation of the mammalian GABAA receptor by type I and type II positive allosteric modulators of the α7 nicotinic acetylcholine receptor

H. Arias, I. Hamachi, G. Akk, 2022, British journal of pharmacology.

(+)-Catharanthine potentiates the GABAA receptor by binding to a transmembrane site at the β(+)/α(-) interface near the TM2-TM3 loop.

H. Arias, G. Akk, R. Adron Harris, 2022, Biochemical pharmacology.

Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content.

Brandon M. Brown, H. Arias, G. Puia, 2016, The international journal of biochemistry & cell biology.

Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.

H. Arias, Katarzyna M Targowska-Duda, Katarzyna M. Targowska-Duda, 2015, The international journal of biochemistry & cell biology.

Angiogenesis modulation by nicotine and nicotinic ligands

S. Mousa, H. Arias, 2010, Journal of Pediatric Biochemistry.

Coronaridine congeners decrease neuropathic pain in mice and inhibit α9α10 nicotinic acetylcholine receptors and CaV2.2 channels

H. Arias, David John Adams, C. Ghelardini, 2020, Neuropharmacology.

Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.

H. Arias, 1998, Biochimica et biophysica acta.

The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS-21): Chemical and Pharmacological Properties

K. Chou, Dongqing Wei, H. Arias, 2006, Marine Drugs.

Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?

H. Arias, 2009, The international journal of biochemistry & cell biology.

Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion.

H. Arias, A. Santamaría, Syed F. Ali, 2009, International review of neurobiology.

Allosterically linked noncompetitive antagonist binding sites in the resting nicotinic acetylcholine receptor ion channel.

M. P. Blanton, H. Arias, E. Bayer, 2002, Archives of biochemistry and biophysics.

Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor.

H. Arias, 1996, Molecular membrane biology.

RESEARCH PAPER Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors

H. Arias, W. Kem, H. Xing, 2009 .

Interaction of barbiturate analogs with the Torpedo californica nicotinic acetylcholine receptor ion channel.

H. Arias, E. McCardy, M. Gallagher, 2001, Molecular pharmacology.

(E)-3-furan-2-yl-N-phenylacrylamide (PAM-4) decreases nociception and emotional manifestations of neuropathic pain in mice by α7 nicotinic acetylcholine receptor potentiation

H. Arias, D. Bagdas, Zulfiye Gul, 2021, Neurological research.

Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states.

H. Arias, C. Bouzat, R. Moaddel, 2009, Biochemistry.

Agonist self‐inhibitory binding site of the nicotinic acetylcholine receptor

H. Arias, 1996, Journal of neuroscience research.

Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.

H. Arias, 1995, Molecular membrane biology.

Molecular Interactions between Ligands and Nicotinic Acetylcholine Receptors Revealed by Studies with Acetylcholine Binding Proteins

H. Arias, 2012 .

Activation and modulation of the nicotinic receptor

H. Arias, C. Bouzat, 2010, Journal of Pediatric Biochemistry.

Positive and negative modulation of nicotinic receptors.

H. Arias, 2010, Advances in protein chemistry and structural biology.

Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats

H. Arias, P. Popik, E. Litwa, 2020, Pharmacological Reports.

Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states

H. Arias, R. Moaddel, Katarzyna M Targowska-Duda, 2010 .

Coronaridine congeners potentiate GABAA receptors and induce sedative activity in mice in a benzodiazepine-insensitive manner

H. Arias, Y. Anouar, P. Scholze, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

α7 Nicotinic acetylcholine receptor-mediated anti-inflammatory actions modulate brain functions

M. Atzori, H. Arias, F. Garcia-Oscos, 2016 .

Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task

R. Schwarcz, J. Bruno, H. Arias, 2020, Psychopharmacology.

Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human alpha7 nicotinic acetylcholine receptor.

Dongqing Wei, H. Arias, D. Feuerbach, 2010, Biochemistry.

α7 Nicotinic acetylcholine receptor potentiation downregulates chemotherapy-induced inflammatory overactivation by overlapping intracellular mechanisms.

H. Arias, I. Marmouzi, D. Buck, 2023, The international journal of biochemistry & cell biology.

The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of &agr;7 Nicotinic Acetylcholine Receptors in Mice

H. Arias, D. Bagdas, M. Damaj, 2015, Anesthesia and analgesia.

Functional and structural interactions between selective serotonin reuptake inhibitors and nicotinic acetylcholine receptors

H. Arias, Katarzyna M Targowska-Duda, J. García-Colunga, 2016 .

Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus.

H. Arias, Ş. Mihailescu, Katarzyna M Targowska-Duda, 2014, European journal of pharmacology.

Interaction of nicotinic receptors with bupropion: Structural, functional, and pre-clinical perspectives

H. Arias, Katarzyna M Targowska-Duda, M. Kruk-Slomka, 2014 .

Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation

H. Arias, C. Loland, A. Michalak, 2021, European Neuropsychopharmacology.

Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study

H. Arias, A. Kaczor, Katarzyna M Targowska-Duda, 2019, Journal of biomolecular structure & dynamics.

3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats

H. Arias, P. Popik, M. Hołuj, 2017, Neuropharmacology.

Pro‐cognitive activity in rats of 3‐furan‐2‐yl‐N‐p‐tolyl‐acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor

H. Arias, P. Popik, G. Puia, 2015, British journal of pharmacology.

Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor

H. Arias, Katarzyna M Targowska-Duda, K. Jóźwiak, 2014, Neuroscience Letters.

Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators

H. Arias, Alessio Gabellini, Laura Braconi, 2023, Molecules.

Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task

R. Schwarcz, J. Bruno, H. Arias, 2020, Psychopharmacology.

Molecular Interactions between Mecamylamine Enantiomers and the Transmembrane Domain of the Human α4β2 Nicotinic Receptor

H. Arias, V. Bondarenko, P. Tang, 2014, Biochemistry.

Procognitive activity in rats of 3-furan-2-yl-Np-tolyl-acrylamide , a positive allosteric modulator of the α 7 nicotinic acetylcholine receptor

H. Arias, P. Popik, G. Puia, 2015 .

(+)-Catharanthine and (-)-18-methoxycoronaridine induce antidepressant-like activity in mice by differently recruiting serotonergic and norepinephrinergic neurotransmission.

P. De Deurwaerdère, H. Arias, G. Di Giovanni, 2022, European journal of pharmacology.

Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors.

H. Arias, Katarzyna M Targowska-Duda, K. Jóźwiak, 2010, Biochemistry.

Nicotine facilitates nicotinic acetylcholine receptor targeting to mitochondria but makes them less susceptible to selective ligands

H. Arias, S. Komisarenko, M. Skok, 2017, Neuroscience Letters.

Molecular interaction of bupropion with nicotinic acetylcholine receptors

H. Arias, 2010, Journal of Pediatric Biochemistry.

Application of In Silico Methods to Support Experimental Data: Interactions of Antidepressants with Nicotinic Acetylcholine Receptors

H. Arias, Katarzyna M Targowska-Duda, K. Jóźwiak, 2013 .

Licensee Oa Publishing London 2013. Creative Commons Attribution License (cc-by) N,6-dimethyltricyclo[5.2.1.0 ]decan-2-amine Enantiomers Interact with the Human Α4β2 Nicotinic Acetylcholine Receptor at Luminal and Non-luminal Domains

H. Arias, Katarzyna M Targowska-Duda, K. Jóźwiak, 2022 .

Structural and functional interaction of (±)-2-(N-tert-butylamino)-3′-iodo-4′-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors

David J. Lapinsky, H. Arias, Katarzyna M Targowska-Duda, 2012, Neurochemistry International.

Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states.

H. Arias, Katarzyna M Targowska-Duda, K. Jóźwiak, 2011, The international journal of biochemistry & cell biology.

Interaction of 18-Methoxycoronaridine with Nicotinic Acetylcholine Receptors in Different Conformational States

S. D. Glick, H. Arias, R. Moaddel, 2011 .

Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors

H. Arias, Katarzyna M Targowska-Duda, K. Jóźwiak, 2010, Neurochemistry International.

Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational states.

S. D. Glick, H. Arias, R. Maciejewski, 2010, Biochimica et biophysica acta.

Molecular mechanisms of nicotine dependence

H. Arias, M. Ortells, 2010, Journal of Pediatric Biochemistry.

Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.

H. Arias, A. Fierro, D. Feuerbach, 2013, The international journal of biochemistry & cell biology.

Nicotine Enhances the Excitability of Gaba Neurons in the Ventral Tegmental Area via Activation of Alpha 7 Nicotinic Receptors on Glutamate Terminals

H. Arias, S. Sudweeks, J. G. Edwards, 2013 .

Functional and structural interaction of (-)-lobeline with human α4β2 and α4β4 nicotinic acetylcholine receptor subtypes.

H. Arias, D. Feuerbach, M. Ortells, 2015, The international journal of biochemistry & cell biology.

Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy.

H. Arias, 2010, Methods in molecular biology.

Novel 1-(1-benzyl-1H-indol-3-yl)-N,N,N-trimethylmethanaminium iodides are competitive antagonists for the human α4β2 and α7 nicotinic acetylcholine receptors

H. Arias, R. Tapia, D. Feuerbach, 2013 .

Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.

H. Arias, C. Bouzat, D. Feuerbach, 2013, Biochemistry.

Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat

H. Arias, M. Romanelli, D. Manetti, 2017, Behavioural Brain Research.

Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.

H. Arias, R. Moaddel, Katarzyna M Targowska-Duda, 2010, The international journal of biochemistry & cell biology.

Different interaction between tricyclic antidepressants and mecamylamine with the human α3β4 nicotinic acetylcholine receptor ion channel

H. Arias, R. Maciejewski, Katarzyna M Targowska-Duda, 2010, Neurochemistry International.

Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants

H. Arias, C. Bouzat, G. Spitzmaul, 2003, Neuropharmacology.

Lipid-protein interactions and effect of local anesthetics in acetylcholine receptor-rich membranes from Torpedo marmorata electric organ.

H. Arias, F. Barrantes, D. Marsh, 2003, Biochemistry.

Effect of local anaesthetics on steroid-nicotinic acetylcholine receptor interactions in native membranes of Torpedo marmorata electric organ.

H. Arias, F. Barrantes, D. Marsh, 1990, Biochimica et biophysica acta.

Neurochemical and behavioral effects elicited by bupropion and diethylpropion in rats

H. Arias, A. Santamaría, 2010, Behavioural Brain Research.

Interaction of merocyanine 540 with nicotinic acetylcholine receptor membranes from Discopyge tschudii electric organ.

H. Arias, F. Barrantes, E. Disalvo, 1994, Biochimica et biophysica acta.

High levels of phosphorylation in minor phospholipids of Discopyge tschudii electrocyte membranes

H. Arias, F. Barrantes, 1987, Neurochemistry International.

Transverse localization of the quinacrine binding site on the Torpedo acetylcholine receptor.

H. Arias, C. Valenzuela, D. Johnson, 1993, The Journal of biological chemistry.

Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes.

H. Arias, M. Heydenreich, B. Schmidt, 2018, Journal of natural products.

Alkaloids Purified from Aristotelia chilensis Inhibit the Human α3β4 Nicotinic Acetylcholine Receptor with Higher Potencies Compared with the Human α4β2 and α7 Subtypes.

H. Arias, Cristian Paz, D. Feuerbach, 2019, Journal of natural products.

Mutational Analysis of Anesthetic Binding Sites and Their Effects on GABAA Receptor Activation and Modulation by Positive Allosteric Modulators of the α7 Nicotinic Receptor

H. Arias, G. Akk, Spencer R. Pierce, 2023, Biomolecules.

Identifying the binding site(s) for antidepressants on the Torpedo nicotinic acetylcholine receptor: [3H]2-azidoimipramine photolabeling and molecular dynamics studies.

J. Trudell, M. P. Blanton, H. Arias, 2008, Biochimica et biophysica acta.

Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.

A. Poso, H. Arias, A. Kaczor, 2015, Biochimica et biophysica acta.

The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor.

H. Arias, 1997, Biochimica et biophysica acta.

Dramatic saccharide-mediated protection of chaotropic-induced deactivation of concanavalin A.

H. Arias, D. Alperin, D. Figlas, 1997, Archives of Biochemistry and Biophysics.

Coronaridine congeners induce sedative and anxiolytic-like activity in naïve and stressed/anxious mice by allosteric mechanisms involving increased GABAA receptor affinity for GABA.

P. De Deurwaerdère, H. Arias, G. Di Giovanni, 2023, European journal of pharmacology.

DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole fumarate), a Novel Derivative of Ibogamine, Inhibits α7 and α9α10 Nicotinic Acetylcholine Receptors by Different Allosteric Mechanisms.

H. Arias, David John Adams, J. McIntosh, 2023, ACS chemical neuroscience.

Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor

Dongqing Wei, H. Arias, D. Feuerbach, 2012 .

Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states.

H. Arias, R. Moaddel, Katarzyna M Targowska-Duda, 2010, The international journal of biochemistry & cell biology.

The Antinociceptive Activity of (E)-3-(thiophen-2-yl)-N-(p-tolyl)acrylamide in Mice Is Reduced by (E)-3-(furan-2-yl)-N-methyl-N-(p-tolyl)acrylamide Through Opposing Modulatory Mechanisms at the α7 Nicotinic Acetylcholine Receptor

H. Arias, David John Adams, C. Ghelardini, 2023, Anesthesia and Analgesia.